Current Cancer Drug Targets
Title:Meet Our Editorial Board Member
Volume: 18 Issue: 9
Author(s): D.M. Raben
Affiliation:
Export Options
About this article
Cite this article as:
Raben D.M. , Meet Our Editorial Board Member, Current Cancer Drug Targets 2018; 18 (9) . https://dx.doi.org/10.2174/156800961809180926114556
DOI https://dx.doi.org/10.2174/156800961809180926114556 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
28
3
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting Angiogenic Pathways in Colorectal Cancer: Complexities, Challenges and Future Directions
Current Drug Targets Meet Our Editor-in-Chief
Clinical Cancer Drugs Empyema and Bronchopleural Fistula Following Lung Resection
Current Respiratory Medicine Reviews Meet Our Assoicate Editor
Current Radiopharmaceuticals Cholesterol, Lipids, Amyloid Beta, and Alzheimers
Current Alzheimer Research Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
Current Cancer Drug Targets CYP24A1 as a Potential Target for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Cytotoxicity of an Ebulin l-Anti-Human CD105 Immunotoxin on Mouse Fibroblasts (L929) and Rat Myoblasts (L6E9) Cells Expressing Human CD105
Medicinal Chemistry Branched Peptides as Therapeutics
Current Protein & Peptide Science Integrated Genomic and Pharmacological Approaches to Identify Synthetic Lethal Genes as Cancer Therapeutic Targets
Current Molecular Medicine Regulatory T Cells in Cancer Biology: A Possible New Target for Biochemical Therapies
Mini-Reviews in Medicinal Chemistry ET-18-OCH3 (Edelfosine): A Selective Antitumour Lipid Targeting Apoptosis Through Intracellular Activation of Fas / CD95 Death Receptor
Current Medicinal Chemistry What Does Systems Biology Mean for Drug Development?
Current Medicinal Chemistry New Molecular Targets of Anticancer Therapy – Current Status and Perspectives
Current Medicinal Chemistry Protein Geranylgeranyltransferase Type 1 as a Target in Cancer
Current Cancer Drug Targets Nur77 Family of Nuclear Hormone Receptors
Current Drug Targets - Inflammation & Allergy AMPK: Therapeutic Target for Diabetes and Cancer Prevention
Current Pharmaceutical Design Chimeric Antigen Receptor-Engineered T-Cells - A New Way and Era for Lymphoma Treatment
Recent Patents on Anti-Cancer Drug Discovery Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting
Current Pharmaceutical Design Antineoplastic Activity of Monocrotaline Against Hepatocellular Carcinoma
Anti-Cancer Agents in Medicinal Chemistry